Risk of cutaneous adverse reactions associated with allopurinol or febuxostat in real-world patients: A nationwide study.

痛风 黄嘌呤氧化酶抑制剂 不利影响 高尿酸血症 中止 尿酸 药物警戒
作者
Chih-Wan Lin,Wei-I Huang,Pi-Hui Chao,Wen-Wen Chen,Fei-Yuan Hsiao
出处
期刊:International Journal of Clinical Practice [Wiley]
卷期号:73 (5) 被引量:11
标识
DOI:10.1111/ijcp.13316
摘要

Aims Allopurinol carries a well-known risk of cutaneous adverse reactions (CARs). Although febuxostat, a xanthine-oxidase inhibitor with different chemical structure, has been considered an alternative to allopurinol, post-marketing case reports of life-threatening febuxostat-related CARs have been reported. We aimed to compare the risk of CARs between allopurinol and febuxostat in real-world settings and to assess the impact of the market entry of febuxostat on allopurinol use and associated CARs. Methods A nationwide study was conducted using Taiwan's National Health Insurance Research Database. In the new-user cohort study, patients who received their first prescriptions of allopurinol or febuxostat were included, and Poisson regression was used to estimate the incidence rate ratios (IRRs) of CARs. In the interrupted time series analysis, time series data on new users and incidence rate of CARs were divided into three periods based on the reimbursement scheme of febuxostat in Taiwan, and segmented regression models were used to estimate changes in both the level and trend in each period. Results We identified 526 cases of CARs with 487 among new users of allopurinol and 39 among new users of febuxostat (incidence rate: 15.37 vs 3.48 per 1000 person-years). Allopurinol was associated with higher risk of CARs (adjusted IRR 5.55, 95% CI [3.97-7.76]), mild CARs (1.86, [1.24-2.81]), severe CARs (16.75, [8.87-31.62]) and fatal CARs (16.18, [5.05-51.83]) than febuxostat. The overall incidence rates of xanthine-oxidase inhibitor-related CARs decreased from 15.28 to 14.28 per 1000 person-years after the initial reimbursement of febuxostat and further decreased to 9.46 after the reimbursement coverage of febuxostat expanded; however, the changes were not statistically significant. Conclusion Febuxostat can be considered an alternative for patients carrying risk factors for allopurinol-related CARs. However, since there were fatal cases of febuxostat-related CARs, the closely monitoring of symptoms of CARs during the initiation of febuxostat is still warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
1秒前
1秒前
1秒前
2秒前
H里波特完成签到,获得积分10
2秒前
cxzdm发布了新的文献求助30
2秒前
lzsxjd发布了新的文献求助10
2秒前
星辰大海应助王伟采纳,获得10
3秒前
SimonL完成签到,获得积分20
3秒前
4秒前
Jonas发布了新的文献求助10
4秒前
老鱼娜娜完成签到,获得积分20
4秒前
Guomin发布了新的文献求助10
5秒前
6秒前
晚晨完成签到 ,获得积分10
6秒前
along完成签到,获得积分10
6秒前
7秒前
机智翼发布了新的文献求助10
7秒前
踏月偷心发布了新的文献求助10
8秒前
xutong de完成签到,获得积分10
8秒前
8秒前
今后应助无昵称采纳,获得10
8秒前
科研通AI5应助可乐兑雪碧采纳,获得10
9秒前
好好学习完成签到 ,获得积分10
9秒前
9秒前
km完成签到,获得积分10
10秒前
Angew来来来完成签到,获得积分10
10秒前
凛冬发布了新的文献求助10
10秒前
花轻完成签到,获得积分10
10秒前
传奇3应助快乐的水绿采纳,获得20
11秒前
星川发布了新的文献求助10
11秒前
lzsxjd完成签到,获得积分20
13秒前
13秒前
娇气的背包完成签到,获得积分10
14秒前
fu完成签到,获得积分10
15秒前
15秒前
15秒前
16秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3970172
求助须知:如何正确求助?哪些是违规求助? 3514982
关于积分的说明 11176568
捐赠科研通 3250212
什么是DOI,文献DOI怎么找? 1795198
邀请新用户注册赠送积分活动 875702
科研通“疑难数据库(出版商)”最低求助积分说明 805004